Subnuclei of interest | Subfield volume, mm3, mean ± SE | F | ηp2* | Volume reduction, %† | p value (unadjusted) | |
---|---|---|---|---|---|---|
OCD (n = 81) | Control (n = 93) | |||||
Left central nucleus | 37 ± 1 | 42 ± 1 | 9.675 | 0.053 | −11.9 | 0.002‡ |
Left basolateral complex | ||||||
Left lateral nucleus | 623 ± 7 | 644 ± 6 | 4.871 | 0.027 | −3.3 | 0.029§ |
Left basal nucleus | 432 ± 5 | 442 ± 5 | 1.823 | 0.010 | −2.3 | 0.18 |
Left accessory basal nucleus | 230 ± 3 | 246 ± 3 | 11.616 | 0.063 | −6.5 | 0.001§ |
Right central nucleus | 39 ± 1 | 45 ± 1 | 14.869 | 0.079 | −13.3 | < 0.001‡ |
Right basolateral complex | ||||||
Right lateral nucleus | 636 ± 8 | 662 ± 8 | 5.71 | 0.032 | −3.9 | 0.018§ |
Right basal nucleus | 442 ± 6 | 461 ± 5 | 5.839 | 0.033 | −4.1 | 0.017§ |
Right accessory basal nucleus | 244 ± 4 | 269 ± 3 | 24.752 | 0.125 | −9.3 | < 0.001§ |
BLA = basolateral complex of the amygdala; CeA = central nucleus of the amygdala; OCD = obsessive–compulsive disorder; SE = standard error.
↵* 0.01 indicates small effect size, 0.06 indicates medium effect size, and 0.14 indicates large effect size.
↵† Percent volume reduction was calculated as (adjusted mean volume of patients with OCD) – (adjusted mean volume of healthy controls) / [adjusted mean volume of healthy controls] × 100%.
↵‡ Significance with a nominal threshold.
↵§ Significance after false discovery rate correction for multiple comparisons.